Article Details

The Zacks Analyst Blog Highlights: AbbVie, Merck, Eli Lilly, Novartis and Pfizer - Entrepreneur

Retrieved on: 2022-02-08 01:05:12

Tags for this article:

Click the tags to see associated articles and topics

The Zacks Analyst Blog Highlights: AbbVie, Merck, Eli Lilly, Novartis and Pfizer - Entrepreneur. View article details on hiswai:

Excerpt

Pfizer stopped clinical development of vupanorsen, which was being evaluated in cardiovascular risk reduction and severe hypertriglyceridemia ...

Article found on: www.entrepreneur.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up